Compare Viva Biotech Holdings with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.93%
0%
11.93%
6 Months
-30.39%
0%
-30.39%
1 Year
12.57%
0%
12.57%
2 Years
278.85%
0%
278.85%
3 Years
32.21%
0%
32.21%
4 Years
-31.12%
0%
-31.12%
5 Years
-71.45%
0%
-71.45%
Viva Biotech Holdings for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
36.46%
EBIT Growth (5y)
29.19%
EBIT to Interest (avg)
1.98
Debt to EBITDA (avg)
2.22
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.33
Tax Ratio
24.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
4.47%
ROE (avg)
1.66%
Valuation key factors
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.42
EV to EBIT
24.32
EV to EBITDA
12.60
EV to Capital Employed
1.39
EV to Sales
2.81
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
5.72%
ROE (Latest)
4.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,154.00
2,381.90
-9.57%
Operating Profit (PBDIT) excl Other Income
480.90
446.30
7.75%
Interest
58.40
195.10
-70.07%
Exceptional Items
48.90
-94.30
151.86%
Consolidate Net Profit
240.70
-110.30
318.22%
Operating Profit Margin (Excl OI)
115.60%
89.40%
2.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -9.57% vs -13.92% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 318.22% vs 81.19% in Dec 2023
About Viva Biotech Holdings 
Viva Biotech Holdings
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






